| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681671 | Clinical Neurology and Neurosurgery | 2018 | 15 Pages |
Abstract
If these findings will be confirmed in larger series, MMP-inhibitors and female hormone receptor-antagonists may be combined to augment chemotherapy efficacy and to attenuate invasion in high-grade meningiomas.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Erdinc Ozek, Deniz Ozcan, Suat Erol Celik, Ahmet Celal Iplikcioglu,